FDA commissioner nomination clears Senate committee
Executive Summary
The Senate Health Committee approves the nomination of Acting FDA Commissioner Lester Crawford to become full commissioner by voice vote June 15. A vote by the full Senate will be delayed, however, due to simultaneous holds: one placed by Sen. Tom Coburn (R-Okla.) over concerns about FDA's relabeling of condoms and another placed by Sens. Patty Murray (D-Wash.) and Hillary Clinton (D-N.Y.) due to FDA's delay in making a decision on the over-the-counter switch application for Barr's Plan B emergency contraceptive...
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.